HER2/neu gene amplification and consequent over expression of HER2/neu receptor have been observed in a significant proportion of human tumours, particularly in breast cancer, and are intimately associated with malignant phenotype and aggressiveness of the malignancy4–7. This evidence concerns the gene ERBB2 and breast cancer.